Deep learning-based rapid generation of broadly reactive antibodies against SARS-CoV-2 and its Omicron variant.

Journal: Cell research
Published Date:

Abstract

No abstract available for this article.

Authors

  • Hantao Lou
    Frontier Research Center for Cell Response, Nankai-Oxford International Advanced Research Institute, College of Life Sciences, Nankai University, Tianjin, China. hantao.lou@nankai.edu.cn.
  • Jianqing Zheng
    The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
  • Xiaohang Leo Fang
    Department of Engineering Science, University of Oxford, Oxford, UK.
  • Zhu Liang
    Tencent Youtu Lab, Shanghai, People's Republic of China.
  • Meihan Zhang
    Frontier Research Center for Cell Response, Nankai-Oxford International Advanced Research Institute, College of Life Sciences, Nankai University, Tianjin, China.
  • Yu Chen
    State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
  • Chunmei Wang
    Chinese Academy for Medical Sciences Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Xuetao Cao
    Frontier Research Center for Cell Response, Nankai-Oxford International Advanced Research Institute, College of Life Sciences, Nankai University, Tianjin, China. caoxt@immunol.org.